MedPath

Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition in Stroke Patients With Cognitive Decline

Not Applicable
Conditions
Stroke Patients With Cognitive Decline
Interventions
Behavioral: Cognitive training
Behavioral: Aerobic exercise training
Behavioral: Sequential combination of aerobic exercise and cognitive training
Registration Number
NCT02550990
Lead Sponsor
Chang Gung Memorial Hospital
Brief Summary

The purpose of this study is to determine the treatment effects of sequential combination of aerobic exercise and cognitive training on cognitive function, physiological markers, daily function, physical function, social participation and quality of life in stroke patients with cognitive decline. The investigators hypothesized that: (1) sequential training protocol can improve outcome measures compared to single mode of training; (2) these treatment effects will retain at 6-month follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
75
Inclusion Criteria
  1. Ischemic or hemorrhagic stroke occurring at least 6 months prior to enrollment
  2. Age range from 20 to 90 years
  3. MMSE score ≥ 19
  4. MoCA<26
  5. Self- or informant-reported memory or cognitive complaints or CDR scale ≤ 0.5
  6. Able to follow the study instruction
  7. Adequate cardiopulmonary function to perform aerobic exercise
  8. Able to walk with or without assistive devices
Exclusion Criteria
  1. Unstable medical history (e.g., recent myocardial infarction) that might limit participation
  2. Concomitant with other neurological disorders (e.g., Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis)
  3. Current participation in another interventional trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive training groupCognitive trainingOne 60-min session of cognitive training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
Aerobic exercise training groupAerobic exercise trainingOne 60-min session of aerobic exercise training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
Sequential training groupSequential combination of aerobic exercise and cognitive trainingOne 30-min session of aerobic exercise training + one 30-min session of cognitive training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.
Primary Outcome Measures
NameTimeMethod
Change scores of Stroop Color-Word testBaseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Montreal Cognitive Assessment (MoCA)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Wechsler Adult Intelligence Scale - Third Edition (WAIS-III)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Wechsler Memory Scale - Third Edition (WMS-III)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Useful Field of View (UFOV)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Dual-task testBaseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

The dual-task tests will be assessed to determine the ability for an individual to perform 2 tasks simultaneously. The investigators will assess the dual-task performance during walking and performing box and block test. The results of the dual-task tests will provide information regarding to whether the 2 tasks compete for the same class of neural resources or one of the tasks can be carried out automatically.

Secondary Outcome Measures
NameTimeMethod
Change scores of Lawton Instrumental Activities of Daily Living Scale (Lawton IADL)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of EuroQol (EQ)-5D questionnaireBaseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Rivermead Mobility Index (RMI)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Plasma lipid levelBaseline, posttest (an expected average of 3 months)

The cholesterol ratio (total cholesterol divided by high-density lipid) will be evaluated to reflect the lipid level in the blood.

Change scores of serum BDNF levelBaseline, posttest (an expected average of 3 months)
Change scores of Antioxidative markerBaseline, posttest (an expected average of 3 months)

Antioxidative markers will be used to reflect the changes on oxidative stress. In particular, we will be analyzing the total antioxidant capacity (TAC).

Change scores of Functional Independence Measure (FIM)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Mobility levelBaseline, posttest (an expected average of 3 months)
Change scores of International Physical Activity Questionnaires (IPAQ)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Glucose indicatorBaseline, posttest (an expected average of 3 months)

HbA1C level will be tested to investigate the relationships between blood glucose level and aerobic exercise.

Change scores of Fugl-Meyer Assessment (FMA)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Community Integration Questionnaire (CIQ)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Genotyping of the BDNF val66met polymorphismBetween baseline and posttest (an expected average of 3 months)
Change scores of Stroke Impact Scale (SIS)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Caregiver Burden (CB) scaleBaseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Timed up and go test (TUG)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of Six-minute walk test (6MWT)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)
Change scores of muscle strengthBaseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

We will evaluate isometric knee flexors and extensors muscle strength using handheld dynamometer. Also, we will use hand dynamometer to measure grip strength of the affected and less affected hand while the participant is seated, with the elbow at 90-degree flexion. We will record the mean value of 3 attempts.

Change scores of Geriatric Depression Scale (GDS)Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

Trial Locations

Locations (6)

Chiayi Chang Gung Memorial Hospital

🇨🇳

Chiayi City, Taiwan

Kaohsiung Chang Gung Memorial Hospital

🇨🇳

Kaohsiung City, Taiwan

Keeling Chang Gung Memorial Hospital

🇨🇳

Keelung City, Taiwan

Chang Gung Memorial Hospital

🇨🇳

Kwei-Shan, Taoyuan, Taiwan

Taipei Chang Gung Memorial Hospital

🇨🇳

Taipei City, Taiwan

Taoyuan Chang Gung Memorial Hospital

🇨🇳

Taoyuan City, Taiwan

© Copyright 2025. All Rights Reserved by MedPath